Trial Profile
Phase 2a Study of TS-133 in Alopecia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2017
Price :
$35
*
At a glance
- Drugs Setafrastat (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 28 Aug 2017 Status changed from recruiting to completed.
- 22 Oct 2016 New trial record